Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Patients receiving tirzepatide at the highest dose achieved mean weight reductions of 20-22% of body weight over 72 weeks, significantly outperforming single-pathway GLP-1 agents
Kiwaki K, Novak CM, Hsu DK, Liu FT, Levine JA
[12] Current data have not demonstrated an increased incidence of MTC in patients treated with GLP-1 receptor agonists, including tirzepatide, though surveillance continues
L.SibilanoR.WatzenboeckM
Emily Watters, a general and bariatric surgeon at GBMC's Comprehensive Obesity Management Program (COMP), recently led a webinar to cut through the noise and give patients the facts
Adjust your technique, angle, or pinch method for next time
US$ 23.50
US$ 26.71
US$ 20.15
